| Literature DB >> 23985381 |
Abstract
AIM: To determine the prevalence of various malignant oral lesions in the UAE and correlate cases of squamous cell carcinomas with age, gender, site, grade, clinical presentations at the time of diagnosis, and the prevalence of neck metastasis.Entities:
Keywords: UAE; biopsy; early detection; neck dissection; oral cancer; prevalence
Mesh:
Year: 2013 PMID: 23985381 PMCID: PMC3756533 DOI: 10.3402/ljm.v8i0.21782
Source DB: PubMed Journal: Libyan J Med ISSN: 1819-6357 Impact factor: 1.743
The distribution of the cases among various hospitals
| Hospitals | Study years | Total no. of oral biopsies retrieved | Malignant lesions | OSCC |
|---|---|---|---|---|
| Tawam | 2008–2011 | 223 | 74 | 60 |
| Mafraq | 2009–2012 | 248 | 21 | 17 |
| Baraha | 2005–2011 | 133 | 44 | 3 |
| Iranian | 2007–2010 | 388 | 8 | 23 |
Note: OSCC, oral squamous cell carcinoma.
Distribution of the various histopathological diagnosis of malignant lesions in the UAE for the studied time periods
| Diagnosis | Frequency | Percentage of malignant tumors (%) |
|---|---|---|
| Malignant neoplasms of epithelial origin | ||
| Squamous cell carcinoma | 103 | 70 |
| Papillary carcinoma (variant) | 8 | 5.4 |
| Spindle cell carcinoma (variant) | 2 | 1.4 |
| Malignant melanoma | 2 | 1.4 |
| Total: 115 | 78.2 | |
| Malignant neoplasms of glandular origin | ||
| Mucoepidermoid carcinoma | 8 | 5.4 |
| Adenoid cystic carcinoma | 4 | 2.7 |
| Adenocarcinoma | 4 | 2.7 |
| Malignant salivary gland tumor (type unspecified) | 2 | 1.4 |
| Clear cell carcinoma | 1 | 0.7 |
| Salivary duct carcinoma | 1 | 0.7 |
| Total: 20 | 13.6 | |
| Malignant neoplasms of mesenchymal origin | ||
| Rhabdomyosarcoma | 4 | 2.7 |
| Ewing's sarcoma | 2 | 1.4 |
| B-cell lymphoma | 2 | 1.4 |
| Burkitt's lymphoma | 2 | 1.4 |
| Plasma cell tumor | 2 | 1.4 |
| Total: 12 | 8.3 | |
| Total | 147 | 100 |
Fig. 1Neck dissection outcome for 77 cases with squamous cell carcinoma.
Comparison of the sensitivity and specificity values of different diagnostic procedures to detect micrometastasis in cN0 patients (5, 35)
| Diagnostic procedure | Sensitivity (%) | Specificity (%) |
|---|---|---|
| CT | 52 | 93 |
| MRI | 65 | 81 |
| PET | 66 | 87 |
| US | 66 | 78 |
| SNB | 93 | 100 |
Note: CT, computed tomography; MRI, magnetic resonance imaging; PET, positron emission tomography; US, ultrasound; SNB, sentinel node biopsy.